Physician profile
David Goldstein
NPI 1073638615
$1,236.99
in general payments reported to CMS, 2019-2025
9 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $66.83 · 2021: $124 · 2022: $192 · 2023: $186 · 2024: $53.77 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $743.91 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $143.67 | 2019-2025 | |
| Allergan, INC. | $120.27 | 2019 | |
| Alnylam Pharmaceuticals INC. | $78.49 | 2022 | |
| Pfizer INC. | $63.32 | 2023-2025 | |
| Boston Scientific Corporation | $26.86 | 2021 | |
| Novo Nordisk INC | $21.81 | 2024 | Rivfloza |
| E.R. Squibb & Sons, L.L.C. | $19.79 | 2022 | |
| Sun Pharmaceutical Industries INC. | $18.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.